Skip to main content
Paul Hamlin, MD, Oncology, New York, NY

PaulAHamlinMD

Oncology • New York, NY

Hematologic Oncology

Clinical Director, Outpatient Lymphoma Service

Request Appointment

Overview of Dr. Hamlin

Dr. Paul Hamlin is the Medical Director of the David H. Koch Center for Cancer Care at MSKCC; He is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from State University of New York Downstate Medical Center College of Medicine, Internship/Residency at NYU, Fellowship at MSKCC and has been in practice 20 years. He specializes in hematologic oncology and is experienced in clinical research, hematologic oncology, hodgkin's lymphoma, biologic therapy, general medical oncology, and geriatric oncology.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 1997 - 2000
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1997

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 1998 - 2026
  • CT State Medical License
    CT State Medical License 2023 - 2025
  • NJ State Medical License
    NJ State Medical License 2010 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor Evolution
    Paul A. Hamlin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
    Paul A. Hamlin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and C...
    Paul A. Hamlin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Aging and Hematologic Disorders: Exploring the Evidence 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Monotherapy Activity with the First CD20-Targeted Immunotoxin, MT-3724, in Subjects with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a phase 2 study in patients with relapsed/refractory B- and T-cell non-Hodgkin lymphoma (... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Backed by Chelsea Clinton’s Venture Capital Fund, This Startup Aims to Make Having Cancer Less Lonely
    Backed by Chelsea Clinton’s Venture Capital Fund, This Startup Aims to Make Having Cancer Less LonelyJanuary 11th, 2021
  • Phase 2 Clinical Study Reports Best Outcomes to Date for Older Hodgkin Lymphoma Patients
    Phase 2 Clinical Study Reports Best Outcomes to Date for Older Hodgkin Lymphoma PatientsSeptember 5th, 2018
  • New Interim Phase 2a Study Results Demonstrate Broad Clinical Activity of Portola Pharmaceuticals' Oral SYK/JAK Inhibitor Cerdulatinib
    New Interim Phase 2a Study Results Demonstrate Broad Clinical Activity of Portola Pharmaceuticals' Oral SYK/JAK Inhibitor CerdulatinibJune 4th, 2018
  • Join now to see all

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Paul Hamlin, Dr. Paul Hamlin, MD, Dr. P Hamlin, Dr. Paul A Hamlin